×

Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione dihydrate, compositions and methods of use thereof

DC CAFC
  • US 10,093,647 B1
  • Filed: 12/20/2017
  • Issued: 10/09/2018
  • Est. Priority Date: 05/26/2017
  • Status: Active Grant
First Claim
Patent Images

1. Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione dihydrate, having an X-ray powder diffraction pattern comprising peaks at 13.9, 16.6, and 25.5 degrees 2θ

  • ±

    0.2 degrees 2θ

    .

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×